Q3 2016 Holdings
Filed 2016-11-14 | 134 holdings | $2.4B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Neurocrine Biosciences, Inc.(NBIX) | COM | 64125C109 | $45.3K | 895,422 | 0.0% |
| Heron Therapeutics, Inc.(HRTX) | COM | 427746102 | $49.2K | 2,857,250 | 0.0% |
| Invitae Corporation(NVTA1EUR) | COM | 46185L103 | $57.4K | 6,554,967 | 0.0% |
| Acorda Therapeutics, Inc. Notes 1.75% 6/15/2021 | NOTE 1.75% 6/15/2021 | 00484MAA4 | $62.8K | $77,083,000 | 0.0% |
| Exelixis, Inc.(EXEL) | COM | 30161Q104 | $63.0K | 4,929,494 | 0.0% |
| Amarin Corporation plc | SPONSORED ADR NEW | 023111206 | $65.8K | 20,630,477 | 0.0% |
| Clovis Oncology, Inc. 2.5% 9/15/2021 | NOTE 2.5% 9/15/2021 | 189464AB6 | $69.1K | $72,758,000 | 0.0% |
| Acorda Therapeutics, Inc. | COM | 00484M106 | $76.4K | 3,661,082 | 0.0% |
| Spark Therapeutics, Inc. | COM | 84652J103 | $79.2K | 1,318,341 | 0.0% |
| Bellicum Pharmaceuticals, Inc. | COM | 079481107 | $96.8K | 4,865,647 | 0.0% |
| BioMarin Pharmaceutical Inc. Notes 1.875% 4/23/2017 | NOTE 1.875% 4/23/2017 | 09061GAD3 | $101.4K | $22,379,000 | 0.0% |
| Aquinox Pharmaceuticals, Inc. | COM | 03842B101 | $140.8K | 10,536,092 | 0.0% |
| DBV Technologies S.A. | SPONSORED ADR | 23306J101 | $200.2K | 5,509,560 | 0.0% |
| Genomic Health, Inc.(GHDX) | COM | 37244C101 | $398.2K | 13,770,302 | 0.0% |
| Incyte Corporation Notes 0.375% 11/15/2018 144A | NOTE 0.375% 11/15/2018 | 45337CAK8 | $491.3K | $259,000,000 | 0.0% |
| Incyte Corporation Notes 1.25% 11/15/2020 144A | NOTE 1.25% 11/15/2020 | 45337CAL6 | $531.2K | $274,500,000 | 0.0% |
| Arbutus Biopharma Corporation(ABUS) | COM | 03879J100 | $621.0K | 180,582 | 0.0% |
| Adaptimmune Therapeutics plc(ADAPY) | SPONSORED ADR | 00653A107 | $705.0K | 100,000 | 0.0% |
| Alnylam Pharmaceuticals, Inc.(ALNY) | COM | 02043Q107 | $769.0K | 11,340 | 0.0% |
| Alexion Pharmaceuticals, Inc.(ALXN) | COM | 015351109 | $801.8K | 6,543,295 | 0.0% |
| Aldeyra Therapeutics, Inc.(ALDX) | COM | 01438T106 | $1.1M | 142,000 | 0.0% |
| Cellectis S.A.(CLLS) | SPONSORED ADS | 15117K103 | $1.2M | 50,000 | 0.0% |
| Incyte Corporation(INCY) | COM | 45337C102 | $2.2M | 23,498,898 | 0.1% |
| Seattle Genetics, Inc. | COM | 812578102 | $2.4M | 44,100,294 | 0.1% |
| Catalyst Pharmaceuticals, Inc.(CPRX) | COM | 14888U101 | $5.6M | 5,102,153 | 0.2% |
| Agios Pharmaceuticals, Inc.(AGIO) | COM | 00847X104 | $11.0M | 207,915 | 0.5% |
| Arrowhead Pharmaceuticals, Inc.(ARWR) | COM | 04280A100 | $13.6M | 1,856,967 | 0.6% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $15.0M | 745,521 | 0.6% |
| BioCryst Pharmaceuticals, Inc.(BCRX) | COM | 09058V103 | $48.4M | 10,963,944 | 2.0% |
| BeiGene, Ltd.(ONC) | SPONSORED ADR | 07725L102 | $58.9M | 1,912,680 | 2.4% |
| Cerus Corporation(CERS) | COM | 157085101 | $81.1M | 13,053,275 | 3.4% |
| BioMarin Pharmaceutical Inc.(BMRN) | COM | 09061G101 | $444.7M | 4,806,483 | 18.4% |
| Acadia Pharmaceuticals Inc.(ACAD) | COM | 004225108 | $821.3M | 25,819,768 | 34.0% |
| AbbVie Inc.(ABBV) | COM | 00287Y109 | $904.6M | 14,343,358 | 37.4% |